6.60
+0.22(+3.45%)
Currency In USD
| Previous Close | 6.38 |
| Open | 6.24 |
| Day High | 6.8 |
| Day Low | 6.21 |
| 52-Week High | 15.1 |
| 52-Week Low | 4.02 |
| Volume | 874,182 |
| Average Volume | 1.27M |
| Market Cap | 358.23M |
| PE | -2.56 |
| EPS | -2.58 |
| Moving Average 50 Days | 6.03 |
| Moving Average 200 Days | 7.68 |
| Change | 0.22 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $203.96 as of July 02, 2025 at a share price of $6.6. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $78.5 as of July 02, 2025 at a share price of $6.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply
GlobeNewswire Inc.
Jun 23, 2025 12:05 PM GMT
GAITHERSBURG, Md., June 23, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has been awarded a $62.4 million contract modification from the Administration for Strategic Preparedness and Response (ASPR), a division
Emergent BioSolutions Announces Addition to Russell 3000® Index
GlobeNewswire Inc.
Jun 20, 2025 12:13 PM GMT
GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the Company will be added to the broad-market Russell 3000® Index, effective after the U.S. market closes on June 27, 2025, as part of the a
Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies
GlobeNewswire Inc.
Jun 05, 2025 11:00 AM GMT
Continued commitment to reducing the number of opioid overdose deaths by expanding access, increasing awareness and educating the public about life-saving naloxone GAITHERSBURG, Md., June 05, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYS